Silence Therapeutics Plc American Depository Share (SLN) is a publicly traded Healthcare sector company. As of May 21, 2026, SLN trades at $6.24 with a market cap of $294.27M and a P/E ratio of -11.51. SLN moved +7.97% today. Year to date, SLN is +5.23%; over the trailing twelve months it is +21.40%. Its 52-week range spans $1.97 to $20.48. Analyst consensus is buy with an average price target of $27.59. Rallies surfaces SLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own SLN include Redmile Group, Duquesne Family, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Silence Therapeutics Plc American Depository Share.
| Metric | Value |
|---|---|
| Price | $6.24 |
| Market Cap | $294.27M |
| P/E Ratio | -11.51 |
| EPS | $-0.54 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.48 |
| 52-Week Low | $1.97 |
| Volume | 158.89K |
| Avg Volume | 0 |
| Revenue (TTM) | $839.00K |
| Net Income | $-75.04M |
| Gross Margin | 79.50% |
5 analysts cover SLN: 0 strong buy, 4 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.59.